Sexual Health & Medical Wellness Sertraline Shows Earlier Modest Benefits for Core Depression and Anxiety Symptoms, UCL-Led Analysis Reveals July 4, 2026 Susilo Ahmad A new comprehensive analysis led by researchers at University College London (UCL) indicates that sertraline, a widely prescribed antidepressant marketed under brand names such as Zoloft and Lustral, delivers modest…
Sexual Health & Medical Wellness Sertraline Shows Earlier Symptom Relief Than Previously Understood, UCL Analysis Reveals May 23, 2026 Susilo Ahmad A new, in-depth analysis spearheaded by researchers at University College London (UCL) has cast a fresh light on the efficacy of sertraline, a widely prescribed antidepressant marketed globally under brand…
Sexual Health & Medical Wellness Sertraline Shows Earlier Symptom Improvement in Depression and Anxiety Than Previously Understood, UCL Re-analysis Reveals May 16, 2026 Susilo Ahmad A widely used antidepressant, sertraline (sold under the brand names Zoloft and Lustral), appears to bring modest yet significant improvements in key depression and anxiety symptoms within the first two…
Sexual Health & Medical Wellness New Analysis Reveals Sertraline’s Earlier Impact on Emotional Symptoms of Depression and Anxiety March 29, 2026 Susilo Ahmad A significant re-evaluation of a widely used antidepressant, sertraline (marketed as Zoloft and Lustral), suggests it delivers modest yet measurable improvements in crucial emotional symptoms of depression and anxiety within…
